U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H6N2O
Molecular Weight 134.1353
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-BENZIMIDAZOLINONE

SMILES

O=C1NC2=C(N1)C=CC=C2

InChI

InChIKey=SILNNFMWIMZVEQ-UHFFFAOYSA-N
InChI=1S/C7H6N2O/c10-7-8-5-3-1-2-4-6(5)9-7/h1-4H,(H2,8,9,10)

HIDE SMILES / InChI

Molecular Formula C7H6N2O
Molecular Weight 134.1353
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Isolation and characterization of Pseudomonas sp. CBW capable of degrading carbendazim.
2010-11
Biodegradation of carbendazim by a novel actinobacterium Rhodococcus jialingiae djl-6-2.
2010-10
Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds.
2010-09-02
Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules.
2010-06-24
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.
2010-06
1-Isopropenyl-1H-1,3-benzimidazol-2(3H)-one.
2010-05-22
Identification of potent, highly constrained CGRP receptor antagonists.
2010-04-15
1-{[(Cyclo-hexyl-oxy)carbon-yl]-oxy}ethyl 3-{[2'-(2-ethyl-2H-tetra-zol-5-yl)biphenyl-4-yl]meth-yl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxyl-ate.
2010-03-31
Rapid access towards follow-up NOP receptor agonists using a knowledge based approach.
2009-11-15
1,3-Bis(hydroxy-meth-yl)benzimidazolin-2-one.
2009-10-17
1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
2009-09-24
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
2009-08-15
The discovery of highly potent CGRP receptor antagonists.
2009-01-01
Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties.
2008-03-15
Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety.
2007-09-01
Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.
2007-08-15
DFT studies of the structure and vibrational assignments of 4-hydroxy quinazoline and 2-hydroxy benzimidazole.
2007-04
Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.
2007-02-15
Benzofused tricycles based on 2-quinoxalinol.
2007-01-09
Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo.
2006-03-01
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
2005-05-05
Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime).
2004-10-11
Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives.
2004-03-08
A theoretical study of substituent effects on tautomerism of 2-hydroxybenzimidazoles.
2003-12
Imidazopyridine/Pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognition.
2003-05-14
Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinity.
2002-09-02
New generation dopaminergic agents. Part 8: heterocyclic bioisosteres that exploit the 7-OH-2-(aminomethyl)chroman D(2) template.
2002-02-11
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:14:37 GMT 2025
Edited
by admin
on Mon Mar 31 19:14:37 GMT 2025
Record UNII
CV8118UZEW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-10383
Preferred Name English
2-BENZIMIDAZOLINONE
Systematic Name English
2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOLE
Systematic Name English
2-HYDROXYBENZIMIDAZOLE
Systematic Name English
2-BENZIMIDAZOLOL
Systematic Name English
2(3H)-BENZIMIDAZOLONE
Systematic Name English
O-PHENYLENEUREA
Common Name English
1,3-DIHYDRO-2H-BENZIMIDAZOLE-2-ONE
Systematic Name English
2H-BENZIMIDAZOL-2-ONE, 1,3-DIHYDRO-
Systematic Name English
NSC-178108
Code English
LANSOPRAZOLE IMPURITY D [EP IMPURITY]
Common Name English
2(3H)-OXOBENZIMIDAZOLE
Common Name English
2-BENZIMIDAZOLONE
Systematic Name English
BENZIMIDAZOLOL [USP IMPURITY]
Common Name English
1H-BENZIMIDAZOL-2-OL
Common Name English
1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE
Systematic Name English
1H-BENZO(D)IMIDAZOL-2-OL
Systematic Name English
RABEPRAZOLE SODIUM IMPURITY K [EP IMPURITY]
Common Name English
LANSOPRAZOLE IMPURITY D
Common Name English
N,N'-(1,2-PHENYLENEUREA)
Common Name English
Code System Code Type Description
ECHA (EC/EINECS)
210-412-4
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
NSC
10383
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
CAS
102976-62-5
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
ALTERNATIVE
EPA CompTox
DTXSID0060642
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
PUBCHEM
11985
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
NSC
178108
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
FDA UNII
CV8118UZEW
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
CAS
615-16-7
Created by admin on Mon Mar 31 19:14:37 GMT 2025 , Edited by admin on Mon Mar 31 19:14:37 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP